Table 1

Descriptive details of study sample for reliability and validity procedures

Subject detailsMean age, years (SD)Mean 7 day step count (range)Mean gait speed, m/s (SD)Median RMI (range; 0–15)
*Indicates significant difference to the matched group (p = 0.001).
MD, primary muscle disorder; MS, multiple sclerosis; PD, Parkinson’s disease.
Reliability study
    Healthy subjects (n = 10) (6 male)43.3 (18.9)6520 (3613–10002)1.49 (0.26)
    Neurology patients (n = 10) (5 male)59.4 (13.4)2961 (716–5301)0.82 (0.38)12 (8–14)
Validity study
    MS patients (n = 10) (0 male) (median EDSS 4.0, range 2.0–6.5)37.9 (10.1)2985 (689–5340) *1.06 (0.43)13 (9–15)
    Matched MS healthy subjects (n = 10)37.5 (12.6)6929 (4347–10002)1.33 (0.21)
    PD patients (n = 10) (7 male)67.1 (8.2)3818 (1611–5391) *0.99 (0.16)13 (9–15)
    Matched PD healthy subjects (n = 10)66.8 (10.8)6347 (4703–9955)1.22(0.23)
    MD patients (n = 10) (6 male)52.1 (12.5)3003 (716–5302) *0.79 (0.23)12 (9–15)
    Matched MD healthy subjects (n = 10)49.5 (16.7)5368 (2886–7758)1.37 (0.3)
    Grouped neurology patients (n = 30)52.4 (15.7)3268 (689–5391)0.95 (0.3)13 (9–15)
    Healthy subjects (n = 30)51.3 (17.9)6214(2886–10002)1.3 (0.25)